Hot Features
Überwachen Sie mehrere Echtzeitkurse von führenden Börsen wie NASDAQ, NYSE, AMEX, Bovespa und mehr.
| Datum | Name des Inhabers | Gehandelte Aktien | Wertspanne ($) | Transaktionstyp | Preisspanne ($) | Aktien am Meldungsende | % Veränderung |
|---|---|---|---|---|---|---|---|
| 2026-05-18 | Mr. Manjunath GangadharanVP & CAO | -426,00 | 54,46k | Sale to Issuer | 127,85 | 3,10k | -12,08% |
| 2026-05-08 | Mr. Robert J. PhelanSenior VP & CFO | -10,00k | 1,26M | Verkauf | 126,21 | 45,85k | -17,91% |
| 2026-05-08 | Mr. Douglas G. BeckSenior VP of Institutional Support Services, General Counsel & Corporate Secretary | -9,62k | 1,22M | Verkauf | 127,03 | 32,76k | -22,69% |
| 2026-05-08 | Dr. Karen Sue CoxPresident of Chamberlain University | -2,00k | 249,00k | Verkauf | 124,50 | 28,17k | -6,63% |
| 2026-05-08 | Mr. Stephen W. BeardCEO & Chairman | -15,87k | 2,08M | Verkauf | 131,25 | 366,05k | -4,16% |
| 2026-04-15 | Mr. Scott Day LilesPresident of Adtalem Medical & Veterinary | -448,00 | 50,40k | Sale to Issuer | 112,49 | 7,40k | -5,71% |
| 2026-03-10 | Mr. Michael William MalafronteLead Independent Director | 36,04k | 3,64M | Kauf | 100,86 - 100,94 | 138,60k | 35,14% |
| 2026-03-03 | Mr. Michael William MalafronteLead Independent Director | 1,20k | 117,56k | Kauf | 97,97 | 101,12k | 1,20% |
| 2025-12-10 | Mr. Stephen W. BeardCEO & Chairman | -5,33k | 0,00 | Other Disposition | - | 381,93k | -1,38% |
| 2025-11-13 | Dr. Betty M. VandenboschIndependent Director | -421,00 | 40,53k | Sale to Issuer | 96,26 | 1,14k | -26,99% |
| 2025-11-13 | Ms. Lisa Warner WardellDirector | -645,00 | 62,09k | Sale to Issuer | 96,26 | 42,81k | -1,48% |
| 2025-11-13 | Mr. Evan TrentInsider | -355,00 | 34,17k | Sale to Issuer | 96,26 | 19,55k | -1,78% |
| 2025-11-13 | Mr. Robert J. PhelanSenior VP & CFO | -623,00 | 59,97k | Sale to Issuer | 96,26 | 55,85k | -1,10% |
| 2025-11-13 | Mr. Kenneth J. PhelanIndependent Director | -392,00 | 37,73k | Sale to Issuer | 96,26 | 18,39k | -2,09% |
| 2025-11-13 | Mr. Michael William MalafronteLead Independent Director | -526,00 | 50,63k | Sale to Issuer | 96,26 | 99,92k | -0,52% |
| 2025-11-13 | Mr. Scott Day LilesPresident of Adtalem Medical & Veterinary | -407,00 | 39,18k | Sale to Issuer | 96,26 | 6,75k | -5,69% |
| 2025-11-13 | Mr. William V. KrehbielIndependent Director | -421,00 | 40,53k | Sale to Issuer | 96,26 | 14,86k | -2,76% |
| 2025-11-13 | Ms. Georgette D. KiserIndependent Director | -425,00 | 40,91k | Sale to Issuer | 96,26 | 16,04k | -2,58% |
| 2025-11-13 | Ms. Donna J. HrinakIndependent Director | -344,00 | 33,11k | Sale to Issuer | 96,26 | 6,77k | -4,83% |
| 2025-11-13 | Mr. Maurice HerreraInsider | -343,00 | 33,02k | Sale to Issuer | 96,26 | 15,77k | -2,13% |
| 2025-11-13 | Mr. Manjunath GangadharanVP & CAO | -94,00 | 9,05k | Sale to Issuer | 96,26 | 2,15k | -4,19% |
| 2025-11-13 | Mr. Douglas G. BeckSenior VP of Institutional Support Services, General Counsel & Corporate Secretary | -361,00 | 34,75k | Sale to Issuer | 96,26 | 42,38k | -0,84% |
| 2025-11-13 | Dr. Karen Sue CoxPresident of Chamberlain University | -310,00 | 29,84k | Sale to Issuer | 96,26 | 30,17k | -1,02% |
| 2025-11-13 | Mr. William W. BurkeIndependent Director | -390,00 | 37,54k | Sale to Issuer | 96,26 | 8,98k | -4,16% |
| 2025-11-13 | Mr. Michael BetzChief Growth & Innovation Officer and President of Walden University | -441,00 | 42,45k | Sale to Issuer | 96,26 | 23,57k | -1,84% |
| 2025-11-13 | Mr. Stephen W. BeardCEO & Chairman | -9,20k | 885,98k | Sale to Issuer | 96,26 | 387,26k | -2,32% |
| 2025-11-10 | Mr. Robert J. PhelanSenior VP & CFO | -1,64k | 155,83k | Sale to Issuer | 95,19 | 62,17k | -2,57% |
| 2025-11-05 | Mr. Kenneth J. PhelanIndependent Director | 508,00 | 49,93k | Kauf | 98,29 | 17,22k | 3,04% |
| 2025-11-04 | Mr. Michael William MalafronteLead Independent Director | 1.000,00 | 91,85k | Kauf | 91,85 | 98,89k | 1,02% |
| 2025-09-08 | Mr. Stephen W. BeardCEO & Chairman | -12,94k | 1,76M | Sale to Issuer | 136,28 | 375,69k | -3,33% |
| 2025-08-28 | Ms. Lisa Warner WardellDirector | -25,48k | 3,37M | Verkauf | 132,38 | 41,89k | -37,82% |
| 2025-08-27 | Ms. Lisa Warner WardellDirector | -18,39k | 2,49M | Verkauf | 135,22 | 67,37k | -21,45% |
| 2025-08-25 | Ms. Lisa Warner WardellDirector | -5,16k | 697,90k | Sale to Issuer | 135,33 | 67,37k | -7,11% |
| 2025-08-23 | Mr. Evan TrentInsider | -9,30k | 1,25M | Sale to Issuer | 134,88 - 135,33 | 20,42k | -31,29% |
| 2025-08-23 | Mr. Robert J. PhelanSenior VP & CFO | -20,96k | 2,83M | Sale to Issuer | 134,88 - 135,33 | 63,81k | -24,72% |
| 2025-08-23 | Mr. Scott Day LilesPresident of Adtalem Medical & Veterinary | -2,78k | 375,51k | Sale to Issuer | 134,88 | 6,16k | -31,12% |
| 2025-08-23 | Ms. Sara HillSenior VP & Chief HR Officer | -1,00k | 135,28k | Sale to Issuer | 134,88 | 1,22k | -45,06% |
| 2025-08-23 | Mr. Maurice HerreraInsider | -11,07k | 1,49M | Sale to Issuer | 134,88 | 15,45k | -41,75% |
| 2025-08-27 | Mr. Manjunath GangadharanVP & CAO | -944,00 | 128,07k | Verkauf | 135,67 | 1,92k | -32,95% |
| 2025-08-23 | Mr. Manjunath GangadharanVP & CAO | -1,17k | 158,08k | Sale to Issuer | 134,88 | 1,92k | -37,89% |
| 2025-08-23 | Dr. Karen Sue CoxPresident of Chamberlain University | -10,11k | 1,36M | Sale to Issuer | 134,88 - 135,33 | 33,33k | -23,28% |
| 2025-08-23 | Mr. Douglas G. BeckSenior VP of Institutional Support Services, General Counsel & Corporate Secretary | -11,25k | 1,52M | Sale to Issuer | 134,88 - 135,33 | 41,94k | -21,15% |
| 2025-08-23 | Mr. Michael BetzChief Growth & Innovation Officer and President of Walden University | -11,46k | 1,55M | Sale to Issuer | 134,88 | 20,90k | -35,42% |
| 2025-08-23 | Mr. Stephen W. BeardCEO & Chairman | -138,85k | 18,73M | Sale to Issuer | 134,88 | 359,42k | -27,87% |
| 2025-08-21 | Ms. Lisa Warner WardellDirector | -12,90k | 1,71M | Verkauf | 132,90 | 80,63k | -13,79% |
| 2025-06-13 | Mr. Douglas G. BeckSenior VP of Institutional Support Services, General Counsel & Corporate Secretary | -3,51k | 428,02k | Sale to Issuer | 121,84 | 28,31k | -11,04% |
Die zuletzt besuchten Aktien werden in diesem Feld angezeigt, so dass Sie leicht zu den Aktien zurückkehren können, die Sie zuvor angesehen haben.
Support: +44 (0) 203 8794 460 | support@advfn.de
Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen
Mit E-Mail registrieren
Haben Sie schon ein Konto? Anmelden
Haben Sie kein Konto? Registrieren
Durch die Registrierung bestätige ich, dass ich die Allgemeinen Geschäftsbedingungen von ADVFN gelesen und verstanden habe und ihnen zustimme und dass ich ein Privatinvestor bin.
Premium
